Ontology highlight
ABSTRACT:
SUBMITTER: Teng M
PROVIDER: S-EPMC7294706 | biostudies-literature | 2020 Jun
REPOSITORIES: biostudies-literature
Teng Mingxing M Ficarro Scott B SB Yoon Hojong H Che Jianwei J Zhou Jing J Fischer Eric S ES Marto Jarrod A JA Zhang Tinghu T Gray Nathanael S NS
ACS medicinal chemistry letters 20200403 6
B-cell lymphoma 6 (BCL6) is a transcriptional repressor frequently deregulated in lymphoid malignancies. BCL6 engages with number of corepressors, and these protein-protein interactions are being explored as a strategy for drug development. Here, we report the development of an irreversible BCL6 inhibitor <b>TMX-2164</b> that uses a sulfonyl fluoride to covalently react with the hydroxyl group of Tyrosine 58 located in the lateral groove. <b>TMX-2164</b> exhibits significantly improved inhibitor ...[more]